Precision Medicine

A novel medical food for IBS shows remarkable efficacy in new studies, exceeding FDA benchmarks for pain relief and solving the long-standing issue of taste.

A major investment in natural killer cell immunotherapy aims to revolutionize treatment for Canada's most fatal women's cancer after decades of stagnation.

The new Gibco CTS DynaXS bioreactor aims to unlock scalable production, making life-saving cell therapies more accessible and affordable for patients.

With its Juveena hydrogel pending FDA approval, Rejoni brings in a commercialization expert to tackle the underserved market for intrauterine adhesions.

A startup's partnership with industry giant Alcon promises to make vision assessment faster, more precise, and accessible to patients everywhere.

Pivotal trial results for a 3D-printed surgical guide show a dramatic drop in follow-up surgeries, heralding a new era of precision for patients.

A new partnership aims to combat a deadly infant disease, highlighting the critical role of human milk and corporate advocacy in saving the most vulnerable lives.

Noema Pharma's investigational drug cendifensine not only cut hot flashes by 92% but also aided weight loss and mood, promising a new non-hormonal era.

A national PSA campaign by Allergy & Asthma Network aims to combat severe health disparities and empower millions to manage their asthma effectively.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Contineum Therapeutics reports encouraging early data for its non-opioid drug PIPE-791, offering a potential new weapon in the fight against chronic pain.

Eli Lilly begins a crucial Phase 2 study for a novel, non-addictive pain drug from Confo Therapeutics, a major step in the hunt for an opioid alternative.

The biotech firm's new genomic intelligence platform aims to de-risk development by providing the first-ever benchmarks for chromosomal integrity.

VectorBuilder tackles key AAV therapy hurdles in ophthalmology, aiming to boost consistency and unlock new treatments for blinding genetic diseases.

A new collaboration leverages a vast cord blood bank and advanced AI to create off-the-shelf cell therapies, promising a new era in regenerative medicine.

PVP Labs' new drug offers potent pain relief without addiction risk. A landmark DEA ruling clears it as a non-controlled substance, set to reshape medicine.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

New research challenges long-held beliefs, revealing a high-risk subset in "safe" tumors and a surprising link between body weight and cancer recurrence.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

New Phase III data shows a dual-action drug delivers significant weight loss while targeting liver health, positioning it as a major new player in the market.